MYGN's logo.
Ticker Symbol: MYGN

Myriad Genetics, Inc.

$29.88 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0000899923

Company Profile

Myriad Genetics Inc., is a leading genetic testing and precision medicine company dedicated to transforming patient lives worldwide. Myriad discovers and commercializes genetic tests that: determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across medical specialties where molecular diagnostics can significantly improve patient care and lower healthcare costs.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2835
Address: 320 S Wakara Way
CEO: R. Bryan Riggsbee
Tags:
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $15.45
Change: -$0.06 ( -0.39%)
Days Range: $15.29 - $15.83
Beta: 1.29
52wk. High: $24.21
52wk. Low: $13.92
Ytd. Change 6.50%
50 Day Moving Average: $16.03
200 Day Moving Average: $19.85
Shares Outstanding: 81883426

Valuation

Market Cap: 126.5B
PE Ratio: -5.05
EPS (TTM): -3.06

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A